KK
AVBP icon

KLP Kapitalforvaltning’s ArriVent BioPharma AVBP Stock Holding History

KLP Kapitalforvaltning’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$99.2K Hold
4,300
– – ﹤0.01% 2054
2025
Q4 		$86.5K Buy
4,300
+1,200
+39% +$25K ﹤0.01% 2105
2025
Q3 		$57.2K Hold
3,100
– – ﹤0.01% 2142
2025
Q2 		$67.5K Hold
3,100
– – ﹤0.01% 2121
2025
Q1 		$57.3K Hold
3,100
– – ﹤0.01% 2175
2024
Q4 		$82.6K Buy
+3,100
New +$89K ﹤0.01% 2145

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

KLP Kapitalforvaltning's AVBP Position: Q1 2026 in Review

KLP Kapitalforvaltning held its ArriVent BioPharma (AVBP) position steady in Q1 2026 at 4,300 shares worth $99.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2054.

KLP Kapitalforvaltning first reported a position in AVBP in Q4 2024 and has held it in 6 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • KLP Kapitalforvaltning held 4,300 shares of ArriVent BioPharma worth $99.2K as of Q1 2026.
  • KLP Kapitalforvaltning left its ArriVent BioPharma share count unchanged in Q1 2026.
  • ArriVent BioPharma made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #2054 holding.
  • KLP Kapitalforvaltning first reported a position in ArriVent BioPharma in Q4 2024 and has held it in 6 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.